Self-administered Intravaginal 2% Lidocaine Gel Prior to Intrauterine Device Insertion in Nulliparous Women

NCT01534520 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Pain

Interventions

DRUG: Lidocaine
DRUG: Placebo

Sponsor

University of Pittsburgh

Collaborators

[object Object]